Low-Dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: A randomized controlled trial
Jacob P. Lalezari, Jeffrey A. Beal, Peter J. Ruane, Calvin J. Cohen, Elizabeth L. Jacobson, David Sundin, D. Pharm, F. Wai Ping Leong, Stephen P. Raffanti, David A. Wheeler, Roger D. Anderson, Philip Keiser, Shannon R. Schrader, C. Jeffrey Goodgame, Corklin R. Steinhart, Robert L. Murphy, Maurice J. Wolin, Kendall A. Smith*
Dive into the research topics of 'Low-Dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: A randomized controlled trial'. Together they form a unique fingerprint.